Search Results

You are looking at 71 - 80 of 691 items for :

  • Refine by Access: All x
Clear All
Full access

Jamie E. Flerlage, Susan M. Hiniker, Saro Armenian, Ellen C. Benya, Adam J. Bobbey, Vivian Chang, Stacy Cooper, Don W. Coulter, Branko Cuglievan, Bradford S. Hoppe, Leidy Isenalumhe, Kara Kelly, Leslie Kersun, Adam J. Lamble, Nicole A. Larrier, Jeffrey Magee, Kwadwo Oduro, Martha Pacheco, Anita P. Price, Kenneth B. Roberts, Christine M. Smith, Aliyah R. Sohani, Erin M. Trovillion, Emily Walling, Ana C. Xavier, Jennifer L. Burns, and Mallory Campbell

multidisciplinary panel of pediatric HL experts, with the goal of providing recommendations on standard treatment approaches based on current evidence. The NCCN Guidelines currently focus on clinical staging of CHL, and treatment strategies are adapted according to

Full access

Joseph G. Rajendran and Benjamin E. Greer

. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer . Int J Gynecol Cancer 2002 ; 12 : 22 – 26 . 2. Goff BA Muntz HG Paley PJ . Impact of surgical staging in women with locally advanced cervical cancer

Full access

Bing-Yen Wang, Ping-Yi Lin, Shiao-Chi Wu, Hui-Shan Chen, Po-Kuei Hsu, Chih-Shiun Shih, Chao-Yu Liu, Chia-Chuan Liu, and Yao-Li Chen

post-CRT pathologic stage and patient outcome. Accurate staging systems play a critical role in cancer treatment. They also provide clinicians and patients with the means to predict survival and select optimal treatment modalities, tailored to disease

Full access

Christopher G. Willett

use of MRI is certainly not new, “there is more adoption of this now in staging. Pretty much all patients receive an MRI,” he said. MRI has an accuracy of up to 94% for T stage and up to 85% for N stage. 1 Neoadjuvant Therapy There is new

Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Don S. Dizon, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Fidel A. Valea, Emily Wyse, Catheryn M. Yashar, Nicole McMillian, and Jillian Scavone

and management of rare, non-SCC histologies. For the purposes of this discussion, vulvar SCC will generally be referred to as “vulvar cancer.” These guidelines utilize the FIGO and AJCC TNM staging systems, which closely align for the staging of

Full access

Brian Badgwell

) view/print certificate. Release date: October 10, 2016; Expiration date: October 10, 2017 Learning Objectives Upon completion of this activity, participants will be able to: Compare and contrast gastric cancer tumor biology, staging

Full access

Kimberly Davies, Matthew Barth, Saro Armenian, Anthony N. Audino, Phillip Barnette, Branko Cuglievan, Hilda Ding, James B. Ford, Paul J. Galardy, Rebecca Gardner, Rabi Hanna, Robert Hayashi, Alexandra E. Kovach, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Kristin Page, Anne F. Reilly, Joanna L. Weinstein, Ana C. Xavier, Nicole R. McMillian, and Deborah A. Freedman-Cass

diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL. These guidelines do not include recommendations for the

Full access

Erich M. Sturgis and K. Kian Ang

limited nodal stage: N0, N1, and N2a). Contemporary studies have found very limited stratification of HPV-associated oropharyngeal cancer outcomes attributable to the TNM staging system, partly because very few HPV-positive cancers present without

Full access

Donald A. Podoloff, Ranjana H. Advani, Craig Allred, Al B. Benson III, Elizabeth Brown, Harold J. Burstein, Robert W. Carlson, R. Edward Coleman, Myron S. Czuczman, Dominique Delbeke, Stephen B. Edge, David S. Ettinger, Frederic W. Grannis Jr., Bruce E. Hillner, John M. Hoffman, Krystyna Kiel, Ritsuko Komaki, Steven M. Larson, David A. Mankoff, Kenneth E. Rosenzweig, John M. Skibber, Joachim Yahalom, JQ Michael Yu, and Andrew D. Zelenetz

The use of positron emission tomography (PET scanning) is increasing rapidly in the United States. The most common use of PET scanning is related to oncology, especially in staging and managing lymphoma, lung cancer, and colorectal cancer ( Figure 1

Full access

Thomas W. Flaig

for primary treatment of stage II disease in cystectomy candidates. For patients ineligible for cystectomy, the recommended primary treatment is concurrent CRT or radiotherapy. Staging Changes In 2017, AJCC incorporated changes in staging criteria for